PROF. SANDRO DA ROCHA

Nanomedicines for Pulmonary Drug Delivery

Formulation of orally inhaled nanomedicines can afford unique opportunities for the treatment of both local lung and systemic diseases. In order to realize those opportunities, however, we need to (i) understand how to modulate the interaction between the nanomedicines and the lung physiological environment and (ii) how to engineer efficient aerosol formulations of those nanomedicines.  In this presentation I will discuss some highlights of our efforts in designing dendrimer nanomedicines for local lung administration, with a focus on cancer.